Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Severe Chronic Idiopathic Urticaria
NCT01960283Phase 3Completed
- Sponsor
- University Hospital Tours
- Start
- Nov 2011
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in chronic idiopathic urticaria (CIU), sponsored by University Hospital Tours. Started Nov 2011; status: completed.
02
Drugs
methotrexate
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT01960283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01960283.